These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Live attenuated vaccines: Historical successes and current challenges. Minor PD Virology; 2015 May; 479-480():379-92. PubMed ID: 25864107 [TBL] [Abstract][Full Text] [Related]
7. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination. Kast WM; Brandt RM; Melief CJ Eur J Immunol; 1993 May; 23(5):1189-92. PubMed ID: 8386667 [TBL] [Abstract][Full Text] [Related]
8. Immunological studies with tobacco mosaic virus protein: differential activation of B cell subpopulations. Rennick DM; Morrow PR; Benjamini E Adv Exp Med Biol; 1982; 150():201-8. PubMed ID: 6183943 [No Abstract] [Full Text] [Related]
9. Immunochemical studies of tobacco mosaic virus--IV. Influence of single amino acid exchanges on the antigenic activity of mutant coat proteins and peptides. Milton RC; Milton SC; von Wechmar MB; van Regenmortel MH Mol Immunol; 1980 Oct; 17(10):1205-12. PubMed ID: 6162094 [No Abstract] [Full Text] [Related]
11. Synthetic vaccines: present and future. Arnon R; Sela M Ann Inst Pasteur Immunol (1985); 1985; 136D(3):271-82. PubMed ID: 3913380 [No Abstract] [Full Text] [Related]
12. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination]. Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624 [TBL] [Abstract][Full Text] [Related]
13. [Vaccines: from seed virus to approval]. Bruhn C Dtsch Med Wochenschr; 2009 Nov; 134(48):p44. PubMed ID: 19941270 [No Abstract] [Full Text] [Related]
14. The concept of virus attenuation in the eighteenth and early nineteenth centuries. Huygelen C Biologicals; 1997 Sep; 25(3):339-45. PubMed ID: 9325002 [No Abstract] [Full Text] [Related]
15. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example. Vol'pina OM; Surovoi AYu ; Ivanov VT Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462 [TBL] [Abstract][Full Text] [Related]
16. Antigenic epitopes of the hepatitis A virus polyprotein. Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261 [TBL] [Abstract][Full Text] [Related]
17. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Kamperschroer C; Quinn DG Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055 [TBL] [Abstract][Full Text] [Related]
19. History of vaccination. Plotkin S Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12283-7. PubMed ID: 25136134 [TBL] [Abstract][Full Text] [Related]
20. Scientific background to the global eradication of rinderpest. Yamanouchi K Vet Immunol Immunopathol; 2012 Jul; 148(1-2):12-5. PubMed ID: 22748234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]